Idiopathic infantile arterial calcification primary prevention

Jump to navigation Jump to search

Idiopathic infantile arterial calcification Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Idiopathic infantile arterial calcification from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

Endoscopy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Idiopathic infantile arterial calcification primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Idiopathic infantile arterial calcification primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

Guidance

FDA on Idiopathic infantile arterial calcification primary prevention

on Idiopathic infantile arterial calcification primary prevention

Idiopathic infantile arterial calcification primary prevention in the news

Blogs on Idiopathic infantile arterial calcification primary prevention

Directions to Hospitals Treating Idiopathic infantile arterial calcification

Risk calculators and risk factors for Idiopathic infantile arterial calcification primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

Overview

Prevention

  • Potential role of genetic markers in the identification of persons at risk.[1] There is a 75% probability to identify the two EPPN1 mutations (one paternal, one maternal) that cause IIAC. Once the mutations are identified, preimplantation genetic diagnosis (PGD) or chorionic villus sampling(CVS) are possible options to identify the condition, either before or during pregnancy.
  • At week 20 of gestation, it is possible to detect an Echogenic Intracardiac Focus (EIF)[2] or intravascular calcifications, particularly in the iliac and [abdominal aorta]. EIF is a small bright spot seen in the baby’s heart on an ultrasound exam. This is thought to represent mineralization, or small deposits of calcium hydroxyapatite,[3] in the muscle of the heart. EIFs are found in about 3-5% of normal pregnancies and cause no health problems.

References

  1. Eller, Philipp; Hochegger, Kathrin; Feuchtner, Gudrun M.; Zitt, Emanuel; Tancevski, Ivan; Ritsch, Andreas; Kronenberg, Florian; Rosenkranz, Alexander R.; Patsch, Josef R. (2007). "Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure". Nephrology Dialysis Transplantation. 23 (1): 321–7. doi:10.1093/ndt/gfm566.
  2. Nasrallah, F. K.; Baho, H.; Sallout, A.; Qurashi, M. (2009). "Prenatal diagnosis of idiopathic infantile arterial calcification with hydrops fetalis". Ultrasound in Obstetrics and Gynecology. 34 (5): 601–4. doi:10.1002/uog.7438. PMID 19813208.
  3. Meradji, M.; De Villeneuve, V.H.; Huber, J.; De Bruijn, W.C.; Pearse, R.G. (1978). "Idiopathic infantile arterial calcification in siblings: Radiologic diagnosis and successful treatment". The Journal of Pediatrics. 92 (3): 401–5. doi:10.1016/S0022-3476(78)80427-2. PMID 416189.


Template:WikiDoc Sources